Skip to content

Symptomatic intracranial artery stenosis multimodal imaging characteristics and the correlation of TCM syndrome and prospective registration study of traditional Chinese medicine intervention

Symptomatic intracranial artery stenosis multimodal imaging characteristics and the correlation of TCM syndrome and prospective registration study of traditional Chinese medicine intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16010080
Enrollment
Unknown
Registered
2016-12-04
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic intracranial artery stenosis

Interventions

Case series:Dengzhanshengmai Capsule

Sponsors

Guangdong Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Aged from 35 to 80 years old; 2) With confirmed diagnosis of acute ischemic stroke by image scanning and confirmed pathogen of atherosclerosis; 3) Symptoms related to ischemic lesion; 4) Time onset from 14 days to 3 month; 5) With confirmed diagnosis of intracranial arterial stenosis by CTA or DSA without intracranial artery occlusion; 6) Without any contraindications of MRA scan; 7) Signed informed consent.

Exclusion criteria

Exclusion criteria: 1) 1 times the upper limit value of creatinine, creatinine clearance rate is less than 30ml/min; 2) allergic to iodine and other contrast agents; 3) Watian drinking water test was 4; 4) mRS classification for 5; 5) the patients with severe heart disease, heart failure, liver dysfunction, renal failure, respiratory failure, malignant tumor, hemorrhage of digestive tract are not expected to complete 1 years of follow-up; psychiatric patients; other reasons can not take medicine on time; pregnant and lactating women; participating in other clinical trials of patients.

Design outcomes

Primary

MeasureTime frame
Fatal stroke or nonfatal stroke or TIA within one year;all cause mortality within one year;

Secondary

MeasureTime frame
To evaluate the change of imaging charateristic of sICAS;

Countries

China

Contacts

Public ContactZhang Xinchun

Guangdong Hospital of Chinese Medicine

xinchun01@163.com+86 13302263552

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026